Canine cancerIMO, if they really expect a licence by the end of 2013 for their MCC canine cancer drug
this mean that they are close to completing their efficacy study : compiling data, filing and getting approval should take at least 1 year
this also means that they can make a deal - based on currently available data - with a major to distribute this drug outside Canada/USA, a company like Bayer
such a deal could bring home a few millions $$, enough to survive until real money comes in